{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P01375",
      "entity_text" : "TNF-alpha",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P00813",
      "entity_text" : "ADA",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "In the years that followed, IFX was followed by other TNF-alpha blockers including adalimumab (ADA) for CD and UC, certolizumab pegol for CD, and golimumab for UC.",
  "reading_complete" : "2020-08-08T17:43:18Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T17:37:25Z",
  "trigger" : "blockers",
  "evidence" : [ "TNF-alpha blockers including adalimumab (ADA" ],
  "pmc_id" : "5421108",
  "score" : 0
}